Hepatologist at Clínica Universidad de Navarra and a leading international investigator in liver cancer systemic therapy and radioembolisation.
Bruno Sangro leads translational research on the Executive Committee of the Cancer Center Clínica Universidad de Navarra and directs the Liver Unit at the clinic. He has been a principal investigator in major hepatocellular carcinoma trials, including immunotherapy combinations, and has contributed to EASL and ESMO guidelines for liver cancer.
Shares Cancer Center Clínica Universidad de Navarra / CIMA, Hepatocellular carcinoma and the tag immunotherapy.
Shares Cancer Center Clínica Universidad de Navarra / CIMA and the tag clinician-scientist.
Shares Biliary tract cancer (cholangiocarcinoma), Hepatocellular carcinoma and the tags clinician-scientist, liver cancer.
Shares the tags clinician-scientist, immunotherapy.
Shares the tags clinician-scientist, immunotherapy.
Shares Hepatocellular carcinoma and the tags clinician-scientist, liver cancer.
Shares Hepatocellular carcinoma and the tags clinician-scientist, liver cancer.
Shares Cancer Center Clínica Universidad de Navarra / CIMA and the tag clinician-scientist.